These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study. Savoia P; Ortoncelli M; Quaglino P; Bernengo MG Dermatol Surg; 2006 Aug; 32(8):1097-102. PubMed ID: 16918576 [No Abstract] [Full Text] [Related]
27. Is KIT an important therapeutic target in small cell lung cancer? Heinrich MC Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5825-8. PubMed ID: 14676102 [No Abstract] [Full Text] [Related]
28. Diabetes research. Researchers puzzle over possible effect of Gleevec. Couzin J Science; 2005 Mar; 307(5716):1711. PubMed ID: 15774738 [No Abstract] [Full Text] [Related]
29. Locally advanced GISTs need aggressive therapy pending the results of trials. Date RS; Mughal MM Ann Surg Oncol; 2008 May; 15(5):1540-1; author reply 1542-3. PubMed ID: 18058180 [No Abstract] [Full Text] [Related]
30. Update on the use of imatinib mesylate. Sawyers CL Clin Adv Hematol Oncol; 2005 Oct; 3(10):757-8. PubMed ID: 16258483 [No Abstract] [Full Text] [Related]
31. Antituberculosis therapy and imatinib for chronic myeloid leukemia. Sorà F; De Matteis S; Di Mario A; Maiuro G; Laurenti L; Chiusolo P; Ardito F; Leone G; Sica S Clin Infect Dis; 2006 Nov; 43(9):1224. PubMed ID: 17029152 [No Abstract] [Full Text] [Related]
32. Central nervous system metastases from imatinib mesylate resistant gastrointestinal stromal tumor. Gerin F; Baloglu O; Morgan JA; Kesari S J Neurooncol; 2007 Apr; 82(2):227-8. PubMed ID: 17106648 [No Abstract] [Full Text] [Related]
33. [c-kit: an irresistible ascension from diagnostic marker to therapeutic]. Scoazec JY Ann Pathol; 2002 Jun; 22(3):173-5. PubMed ID: 12410099 [No Abstract] [Full Text] [Related]
34. Cancer drug effective in RA. Duke Med Health News; 2006 Dec; 12(12):2. PubMed ID: 17294533 [No Abstract] [Full Text] [Related]
35. [Gastrointestinal stromal tumors: a new model for target therapy]. Tonini G; Vincenzi B; La Cesa A Clin Ter; 2003; 154(2):75-6. PubMed ID: 12856363 [No Abstract] [Full Text] [Related]
36. St. John's wort reduces effectiveness of anticancer medication. Health News; 2005 Feb; 11(2):13. PubMed ID: 15732155 [No Abstract] [Full Text] [Related]
37. FDA approves Gleevec for pediatric leukemia. FDA Consum; 2003; 37(4):6. PubMed ID: 12971334 [No Abstract] [Full Text] [Related]
38. Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors? Hohenberger P Nat Clin Pract Oncol; 2008 May; 5(5):240-1. PubMed ID: 18349856 [No Abstract] [Full Text] [Related]
39. PDGFR inhibition in brain tumours--oft expectation fails where most it promises. Raymond E Eur J Cancer; 2009 Sep; 45(13):2236-8. PubMed ID: 19540747 [No Abstract] [Full Text] [Related]
40. [Targeted therapy with imatinib has reformed the treatment of chronic myeloid leukemia]. Nielsen JL Ugeskr Laeger; 2003 May; 165(20):2111. PubMed ID: 12812107 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]